KCR is a full service CRO creating value for biotechnology and pharmaceutical organizations.
Founded in 1997, our expert teams support clients with professional clinical development capabilities across three main areas: Trial Execution, Consulting and Placement.
KCR operates across North America, Europe, and Australia, with main office locations in Boston, US; Berlin, Germany; and Warsaw, Poland. Our geographical coverage across 25+ countries, cutting-edge technical capabilities and tailored offerings allow for the optimized delivery of solutions to develop life-changing therapies.
KCR offers access to an estimated population of 1.1 billion people.
For more information visit www.kcrcro.com
We see the human behind every number.
|
|
|
501-1,000 employees
View all KCR employees
|
|
Pharmaceuticals
|
|
30 Rowes Wharf, Suite 430, Boston, MA 02110, US
|
|
1997
|
|
Pharmacovigilance, Project Management, Cro, Biometrics, Biostatistics, Clinical Development, Data Management, Clinical Monitoring, Functional Service Provider, Late Phase, Medical & Regulatory Affairs, Clinical Quality Assurance & Training, Site Set Up And Contracting
|
Kcr Kehar is the CEO of KCR. To contact Kcr Kehar email at [email protected].
The decision makers in KCR are Anna Baran, Charmaine Scott, Darral Walker, etc. Click to Find KCR decision makers emails.
KCR offers a comprehensive range of services designed to support the clinical development needs of biotechnology and pharmaceutical organizations. Our services include Pharmacovigilance, Project Management, Biometrics, Biostatistics, Clinical Development, Data Management, Clinical Monitoring, and Medical & Regulatory Affairs. We also provide Clinical Quality Assurance & Training, Site Setup and Contracting, and Functional Service Provider solutions to ensure that our clients can navigate the complexities of clinical trials effectively.
KCR prioritizes quality through a robust Clinical Quality Assurance program that encompasses all aspects of our clinical trials. Our expert teams implement rigorous quality control measures, conduct regular audits, and provide comprehensive training to ensure compliance with regulatory standards. We also utilize advanced data management and biometrics techniques to maintain data integrity and accuracy throughout the clinical development process.
KCR primarily supports the biotechnology and pharmaceutical industries. Our expertise extends across various therapeutic areas, including oncology, neurology, cardiology, and rare diseases. We understand the unique challenges faced by these industries and tailor our services to meet their specific needs, ensuring that our clients can successfully bring their products to market.
Yes, KCR has extensive experience in managing late-phase clinical trials. Our dedicated teams are equipped to handle the complexities associated with late-phase studies, including post-marketing surveillance and real-world evidence generation. We work closely with our clients to design and execute studies that meet regulatory requirements and provide valuable insights into the safety and efficacy of their products.
Pharmacovigilance is a critical component of KCR's service offerings. Our Pharmacovigilance team monitors and assesses the safety of pharmaceutical products throughout their lifecycle. We ensure that adverse events are reported in compliance with regulatory requirements, conduct risk assessments, and provide our clients with actionable insights to enhance patient safety and product efficacy.
KCR provides comprehensive support in Medical & Regulatory Affairs to help clients navigate the complex regulatory landscape. Our experts assist with the preparation and submission of regulatory documents, ensure compliance with local and international regulations, and facilitate communication with regulatory authorities. We aim to streamline the approval process for our clients, enabling them to bring their products to market more efficiently.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.